Paper38677331
Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice.
Buzzi B and 3 others. Behav Brain Res, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Nelotanserin, a selective 5-HT2A receptor inverse agonist, attenuates aspects of nicotine withdrawal but not reward in mice. Papers, record 38677331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38677331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Substance Withdrawal Syndrome | Major topic |
| Reward | Major topic |
| Nicotine | Major topic |
| Mice, Inbred ICR | Major topic |
| Serotonin 5-HT2 Receptor Agonists | Major topic |
| Animals | |
| Male | |
| Mice | |
| Dose-Response Relationship, Drug | |
| Tobacco Use Disorder | |
| Hyperalgesia | |
| Receptor, Serotonin, 5-HT2A | |
| Anxiety | |
| Nicotinic Agonists |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 DA033934 | NIDA NIH HHS | United States | P30DA033934 | PubMed and NIH | NIH RePORTER |
| T32 DA007027 | NIDA NIH HHS | United States | T32DA007027 | PubMed | NIH RePORTER |
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22342986 | Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement. | Neuropharmacology | 2012 | https://conductscience.org/library/papers/22342986 | PubMed |
| 2 | 37515363 | The 5-HT2A/2C inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset. | Eur J Neurosci | 2024 | https://conductscience.org/library/papers/37515363 | PubMed |
| 3 | 32145488 | Suppression of cocaine relapse-like behaviors upon pimavanserin and lorcaserin co-administration. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/32145488 | PubMed |
| 4 | 28095732 | An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. | J Psychopharmacol | 2017 | https://conductscience.org/library/papers/28095732 | PubMed |
| 5 | 11441424 | Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. | Psychopharmacology (Berl) | 2001 | https://conductscience.org/library/papers/11441424 | PubMed |
| 6 | 20153341 | Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal. | Neuropharmacology | 2010 | https://conductscience.org/library/papers/20153341 | PubMed |
| 7 | 25739427 | Cartography of 5-HT1A and 5-HT2A Receptor Subtypes in Prefrontal Cortex and Its Projections. | ACS Chem Neurosci | 2015 | https://conductscience.org/library/papers/25739427 | PubMed |
| 8 | 32522572 | Central 5-HT receptors and their function; present and future. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/32522572 | PubMed |
| 9 | 4148000 | Alteration of 5-hydroxytryptamine-14C efflux by nicotine in rat brain area slices. | Neuropharmacology | 1973 | https://conductscience.org/library/papers/4148000 | PubMed |
| 10 | 20627663 | The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats. | Eur Neuropsychopharmacol | 2010 | https://conductscience.org/library/papers/20627663 | PubMed |
| 11 | 25505168 | Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. | Pharmacol Rev | 2015 | https://conductscience.org/library/papers/25505168 | PubMed |
| 12 | 19090322 | APD125, a selective serotonin 5-HT(2A) receptor inverse agonist, significantly improves sleep maintenance in primary insomnia. | Sleep | 2008 | https://conductscience.org/library/papers/19090322 | PubMed |
| 13 | 15565434 | Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists. | Psychopharmacology (Berl) | 2005 | https://conductscience.org/library/papers/15565434 | PubMed |
| 14 | 24682754 | On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis. | Neurochem Res | 2014 | https://conductscience.org/library/papers/24682754 | PubMed |
| 15 | 18184829 | Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. | J Pharmacol Exp Ther | 2008 | https://conductscience.org/library/papers/18184829 | PubMed |
| 16 | 19841476 | Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia. | J Pharmacol Exp Ther | 2010 | https://conductscience.org/library/papers/19841476 | PubMed |
| 17 | 9718253 | 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. | Pain | 1998 | https://conductscience.org/library/papers/9718253 | PubMed |
| 18 | 1352387 | Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. | Neurochem Res | 1992 | https://conductscience.org/library/papers/1352387 | PubMed |
| 19 | 33541678 | 5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence. | Prog Brain Res | 2021 | https://conductscience.org/library/papers/33541678 | PubMed |
| 20 | 6805027 | Effects of chronic nicotine administration on the response and adaptation to stress. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6805027 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HTR2A | 3356 | PubTator's text mining | https://conductscience.org/library/genes/3356 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38677331
GET https://conductscience.org/api/papers/v1/38677331/references?page=2